… from key sources, including the National Cancer Institute, achieving an 11-fold return … investigators have received the prestigious National Cancer Institute Method to Extend Research in … both early-stage and advanced lung cancers. A Baltimore native, Dr. …

Exploring the combination with atezolizumab and radiation therapy Study led by Yale University MADRID, Spain and CAMBRIDGE, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical …

North America leads the PDX market, backed by strong biotech infrastructure, CRO presence, and advanced cancer research funding. AUSTIN, TX, UNITED STATES, February 11, 2026 /⁨EINPresswire.com⁩/ -- The Patient Derived Xenograft (PDX) Models Market …

… are high: to detect lung tumors earlier in the most at … cancers. Coordinated by the National Cancer Institute, this program will target … implicated in approximately 85% of lung cancers. Each year, more than … two out of ten lung cancers are diagnosed at a …

Introduction Lung cancer remains the foremost cause of cancer-related mortality worldwide, with an estimated 1.8 million deaths reported in 2022.1 The emergence of immune checkpoint inhibitors (ICIs), particularly those targeting programmed cell death …

TOPLINE: A history of tuberculosis (TB) and a history of chronic bronchitis were associated with an increased risk for lung cancer in individuals who had never smoked, whereas asthma had a positive, nonsignificant association overall and a significant …

SpotitEarly, a company that uses cancer sniffing dogs in combination with artificial intelligence technology, has established a new research partnership to see whether its approach is effective in the early detection of lung cancer. In September, …

Lung cancer remains the leading cause of cancer death for both men and women in the United States in 2026, even as overall cancer mortality continues to decline, according to the American Cancer Society’s recently released “Cancer Facts & Figures 2026” …

Wei-Xuan Xu,1,* Si-Miao Gao,1,* Pei-Chan Zheng,2,* Jia-Lin Chen,1 Xin-Ying Guo,1 Cheng Li,1 Xiang-Long Chen,1 Si-Ning Tang,1 Yun-Ying Nie,1 Lin-Bin Lu,1 Xiong Chen1 1Department of Oncology, Mengchao Hepatobiliary Hospital of Fujian …

UK Markey Cancer Center is the first site in the country to open a clinical trial for ZG006 (Alveltamig), an experimental drug that works by connecting disease-fighting T cells to cancer cells, allowing the body’s immune system to attack the cancer. RT’s …